Search
Amneal Pharmaceuticals Inc
AMRXAdd to Watchlist
18.320USD
-0.180-0.97%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.76BMarket Cap
47.25P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Amneal Pharmaceuticals Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 13.50, with a high of 15.00 and a low of 13.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
18.844
Target Price
-1.34%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Amneal Pharmaceuticals Inc
AMRX
5
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Amneal Pharmaceuticals Inc's expected revenue for the next quarter?
Amneal Pharmaceuticals Inc's expected revenue is 808.88M.
What is Amneal Pharmaceuticals Inc's price target?
Analysts forecast that Amneal Pharmaceuticals Inc's price target is USD 13.50, with the highest forecast at USD 15.00 and the lowest forecast at USD 13.00.
How have Amneal Pharmaceuticals IncAMRX's recent earnings per share performed?
The market expectation was USD 0.18, while Amneal Pharmaceuticals IncAMRX's earnings per share (EPS) for the previous quarter was USD 0.20. EPS for the next quarter is expected at USD 0.23.
What is the analyst rating for Amneal Pharmaceuticals Inc?
Based on the ratings of Amneal Pharmaceuticals Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.